Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
More than 390 million children and adolescents were overweight or obese as of 2022, according to the World Health ...
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
States with the lowest number of high school and college graduates also have the highest percentage of obese citizens. This ...
Obesity also contributes to other risk factors for heart disease, including high cholesterol, high blood pressure, Type 2 ...
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
Studies have revealed that obesity and eating disorders disrupt the brain's normal response to food entering the stomach and ...